Nutrients,
Journal Year:
2024,
Volume and Issue:
16(21), P. 3741 - 3741
Published: Oct. 31, 2024
Conventional
cancer
treatments
include
surgical
resection,
chemotherapy,
hyperthermia,
immunotherapy,
hormone
therapy,
and
locally
targeted
therapies
such
as
radiation
therapy.
Standard
often
require
the
use
of
multiple
agents,
which
can
activate
nuclear
factor
kappa
B
(NF-κB)
in
tumor
cells,
leading
to
reduced
cell
death
increased
drug
resistance.
Moreover,
agents
also
contributes
added
toxicity,
resulting
poor
treatment
outcomes.
Cancer
cells
gradually
develop
resistance
almost
all
chemotherapeutics
through
various
mechanisms,
efflux,
alterations
metabolism
transport,
changes
signal
transduction
pathways,
enhanced
DNA
repair
capacity,
evasion
apoptosis,
mutations,
reactivation
targets,
interaction
with
microenvironment,
cell-stroma
interactions,
epithelial–mesenchymal
transition
(EMT)-mediated
chemoresistance,
epigenetic
modifications,
metabolic
alterations,
effect
stem
(CSCs).
Developing
new
strategies
improve
chemotherapy
sensitivity
while
minimizing
side
effects
is
essential
for
achieving
better
therapeutic
outcomes
enhancing
patients’
quality
life.
One
promising
approach
involves
combining
conventional
propolis
its
flavonoids.
These
natural
compounds
may
enhance
response
reducing
toxicity.
Propolis
components
sensitize
chemotherapeutic
likely
by
inhibiting
NF-κB
activation,
reprogramming
tumor-associated
macrophages
(TAMs;
an
M2-like
phenotype),
thereby
release
matrix
metalloproteinase
(MMP)-9,
cytokines,
chemokines,
vascular
endothelial
growth
(VEGF).
By
TAMs,
overcome
EMT-mediated
disrupt
crosstalk
between
CSCs,
inhibit
maintenance
stemness,
reverse
acquired
immunosuppression,
thus
promoting
antitumor
mediated
cytotoxic
T-cells.
This
review
highlights
potential
flavonoids
modulate
responsiveness
modalities.
The
evidence
suggests
that
novel
incorporating
could
be
developed
positive
cytotoxicity
peripheral
blood
leukocytes,
liver,
kidney
cells.
Therefore,
polyphenolic/flavonoid
hold
combination
clinical
types
cancers.
Molecules,
Journal Year:
2022,
Volume and Issue:
27(23), P. 8367 - 8367
Published: Nov. 30, 2022
Natural
products
have
been
an
invaluable
and
useful
source
of
anticancer
agents
over
the
years.
Several
compounds
synthesized
from
natural
by
modifying
their
structures
or
using
naturally
occurring
as
building
blocks
in
synthesis
these
for
various
purposes
different
fields,
such
biology,
medicine,
engineering.
Multiple
modern
costly
treatments
applied
to
combat
cancer
limit
its
lethality,
but
results
are
not
significantly
refreshing.
products,
which
a
significant
new
therapeutic
drugs,
currently
being
investigated
potential
cytotoxic
shown
positive
trend
preclinical
research
prompted
numerous
innovative
strategies
order
expedite
clinical
research.
becoming
increasingly
important
drug
discovery
due
high
molecular
diversity
novel
biofunctionality.
Furthermore,
can
provide
superior
efficacy
safety
unique
properties.
The
objective
current
review
is
overview
emergence
treatment
prevention
cancer,
chemosensitizers,
immunotherapeutics,
combinatorial
therapies
with
other
formulations
mechanisms
underlying
Cancers,
Journal Year:
2023,
Volume and Issue:
15(15), P. 3900 - 3900
Published: July 31, 2023
Cancer
is
a
global
health
burden
responsible
for
an
exponentially
growing
number
of
incidences
and
mortalities,
regardless
the
significant
advances
in
its
treatment.
The
identification
hallmarks
cancer
major
milestone
understanding
mechanisms
that
drive
initiation,
development,
progression.
In
past,
have
been
targeted
to
effectively
treat
various
types
cancers.
These
conventional
drugs
shown
therapeutic
efficacy
but
continue
impose
unfavorable
side
effects
on
patients.
Naturally
derived
compounds
are
being
tested
search
alternative
anti-cancer
drugs.
Steroidal
saponins
group
naturally
occurring
primarily
exist
as
secondary
metabolites
plant
species.
Recent
studies
suggested
steroidal
possess
capabilities.
This
review
aims
summarize
recent
findings
inhibitors
covers
key
published
between
years
2014
2024.
It
reported
inhibit
cancer,
poor
bioavailability
insufficient
preclinical
limit
their
utilization.
International Journal of Molecular Sciences,
Journal Year:
2021,
Volume and Issue:
22(20), P. 11069 - 11069
Published: Oct. 14, 2021
The
ongoing
COVID-19
pandemic,
caused
by
the
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
became
a
globally
leading
public
health
concern
over
past
two
years.
Despite
development
and
administration
of
multiple
vaccines,
mutation
newer
strains
challenges
to
universal
immunity
has
shifted
focus
lack
efficacious
drugs
for
therapeutic
intervention
disease.
As
with
SARS-CoV,
MERS-CoV,
other
non-respiratory
viruses,
flavonoids
present
themselves
as
promising
given
their
success
in
silico,
vitro,
vivo,
more
recently,
clinical
studies.
This
review
focuses
on
data
from
vitro
studies
analyzing
effects
various
key
SARS-CoV-2
targets
presents
an
analysis
structure-activity
relationships
same.
From
27
primary
papers,
69
were
investigated
activities
against
targets,
ranging
3C-like
protease
(3CLpro)
less
explored
nucleocapsid
(N)
protein;
most
quercetin
myricetin
derivatives,
baicalein,
baicalin,
EGCG,
tannic
acid.
We
further
silico
featuring
list
involving
potential
flavonoid-rich
extracts
combination
synthetic
or
polyphenols
suggest
prospects
future
SARS-CoV-2.
Molecules,
Journal Year:
2022,
Volume and Issue:
27(6), P. 1794 - 1794
Published: March 9, 2022
Cancer
is
a
major
disease
with
high
mortality
rate
worldwide.
In
many
countries,
cancer
considered
to
be
the
second
most
common
cause
of
death
after
cardiovascular
disease.
The
clinical
management
continues
challenge
as
conventional
treatments,
such
chemotherapy
and
radiation
therapy,
have
limitations
due
their
toxicity
profiles.
Unhealthy
lifestyle
poor
dietary
habits
are
key
risk
factors
for
cancer;
having
healthy
diet
may
minimize
risk.
Epidemiological
studies
shown
that
fruit
vegetable
intake
in
our
regular
can
effectively
reduce
developing
certain
types
cancers
contents
antioxidants
phytochemicals.
vitro
vivo
phytochemicals
exert
significant
anticancer
effects
free
radical
scavenging
capacity
potential.
There
has
been
extensive
research
on
protective
different
cancers.
This
review
attempts
give
an
overview
etiology
assesses
role
phytonutrients
prevention
cancers,
which
makes
present
distinct
from
others
available.
Translational Oncology,
Journal Year:
2022,
Volume and Issue:
27, P. 101596 - 101596
Published: Dec. 5, 2022
Cancer
prevalence
and
its
rate
of
incidence
are
constantly
rising
since
the
past
few
decades.
Owing
to
toxicity
present-day
antineoplastic
drugs,
it
is
imperative
explore
safer
more
effective
molecules
combat
and/or
prevent
this
dreaded
disease.
Flavonoids,
a
class
polyphenols,
have
exhibited
multifaceted
implications
against
several
diseases
including
cancer,
without
showing
significant
towards
normal
cells.
Shredded
pieces
evidence
suggest
that
flavonoids
can
enhance
drug
sensitivity
suppress
proliferation,
metastasis,
angiogenesis
cancer
cells
by
modulating
oncogenic
or
oncosuppressor
microRNAs
(miRNAs,
miRs).
They
play
pivotal
roles
in
regulation
various
biological
pathological
processes,
cancers.
In
present
review,
structure,
chemistry
miR
targeting
efficacy
quercetin,
luteolin,
silibinin,
genistein,
epigallocatechin
gallate,
cyanidin
types
comprehensively
discussed.
miRs
considered
as
next-generation
medicine
recent
times,
their
naturally
occurring
could
be
deemed
signature
step.
We
anticipate
our
compilations
related
miRNA-mediated
might
catapult
clinical
investigations
affirmation
future.
The EPMA Journal,
Journal Year:
2022,
Volume and Issue:
13(1), P. 1 - 7
Published: March 1, 2022
According
to
GLOBOCAN,
about
1.41
million
new
prostate
cancer
(PCa)
cases
were
registered
in
the
year
2020
globally.
The
corresponding
socio-economic
burden
is
enormous.
Anti-cancer
mRNA-based
therapy
a
promising
approach,
principle
of
which
currently
applied
for
anti-COVID-19
vaccination,
undergoing
detailed
investigation
populations
considering
its
short-
and
long-term
effectiveness
potential
side
effects.
Pragmatically
considered,
it
will
take
years
or
even
decades
make
mRNA
working
any
type
cancers,
if
possible,
individual
malignancy
sub-types
are
many
specifically
PCa.
Actually,
costs
treating
PCa
increasing
more
rapidly
than
those
other
cancer.
trend
has
be
reversed
now,
not
couple
years.
In
general,
two
main
components
making
reactive
(management
clinically
manifested
disease)
treatment
particularly
expensive.
On
one
hand,
incidence
disease
metastatic
as
subtype.
To
this
end,
rates
young
middle-aged
male
sub-populations
should
taken
into
account
contributor
potentially
developed
later
on
life.
patient
stratification
differentiate
between
non-metastatic
(no
need
an
extensive
costly
treatment)
aggressive
subtypes
requiring
personalised
algorithms
challenging.
Considering
current
statistics,
becomes
obvious
that
medicine
got
at
limit
management.
Multi-professional
expertise
unavoidable
create
implement
anti-PCa
programmes
population.
our
strategic
paper,
we
exemplify
challenging
management
by
providing
expert
recommendations
primary
(health
risk
assessment),
secondary
(prediction
prevention
PCa)
tertiary
(making
palliative
care
chronic
framework
predictive,
preventive
medicine.
Antioxidants,
Journal Year:
2023,
Volume and Issue:
12(3), P. 586 - 586
Published: Feb. 27, 2023
Citrus
(genus
L.)
fruits
are
essential
sources
of
bioactive
compounds
with
antioxidant
properties,
such
as
flavonoids.
These
polyphenolic
divided
into
subclasses,
in
which
flavanones
the
most
prominent.
Among
them,
naringenin
and
hesperidin
emerging
anticancer
potential,
especially
for
breast
cancer
(BC).
Several
mechanisms
have
been
proposed,
including
modulation
epigenetics,
estrogen
signaling,
induction
cell
death
via
regulation
apoptotic
signaling
pathways,
inhibition
tumor
invasion
metastasis.
However,
this
information
is
sparse
literature
needs
to
be
brought
together
provide
an
overview
how
can
serve
therapeutic
tools
drug
development
a
successful
co-adjuvant
strategy
against
BC.
This
review
detailed
context
highlighted
could
interfere
BC
carcinogenesis
helpful
potential
alternative
treatment.